You are here:
EVALUATION OF THE POTENTIAL CARCINOGENICITY OF AMITROLE
Citation:
EVALUATION OF THE POTENTIAL CARCINOGENICITY OF AMITROLE. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/8-91/060.
Description:
Amitrole is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. vidence on potential carcinogenicity from animal studies is "Sufficient," and the evidence from human studies is "Inadequate." he potency factor (F) for amitrole is estimated to be 3.30 (mg/kg/day)-1, placing it in potency group 2 according to the CAG's methodology for evaluating potential carcinogens. ombining the weight-of-evidence group and the potency group, amitrole is assigned a "MEDIUM" hazard ranking for the purposes of RQ adjustment.
Record Details:
Record Type:DOCUMENT( REPORT )
Product Published Date:05/24/2002
Record Last Revised:04/16/2004
Record ID:
35936